Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
703 Engineered exosomes with altered cellular tropism achieve targeted STING agonist delivery and single-agent tumor control in vivo
Compose a Response to This Article
Other responses
No responses have been published for this article.
